PRIMARY PERITONEAL
Clinical trials for PRIMARY PERITONEAL explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat ovarian cancer
Disease control Recruiting nowThis study is testing an experimental drug called TORL-1-23 for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to standard platinum-based chemotherapy. The drug specifically targets cancer cells that have a protein called CLD…
Matched conditions: PRIMARY PERITONEAL
Phase: PHASE2 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug trial aims to control Tough-to-Treat ovarian cancer
Disease control Recruiting nowThis study is testing an experimental drug called mirvetuximab soravtansine for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to platinum-based chemotherapy. The main goals are to find the best dosing schedule and to see how…
Matched conditions: PRIMARY PERITONEAL
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists test if common drug alters cancer Medicine's strength
Knowledge-focused Recruiting nowThis study aims to understand how a drug called itraconazole, often used to treat fungal infections, affects the levels of a new experimental cancer drug (AZD5335) in the body. It will involve about 24 people with advanced ovarian, fallopian tube, or primary peritoneal cancer who…
Matched conditions: PRIMARY PERITONEAL
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC